help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, R. J.
Right arrow Articles by Kaplan, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, R. J.
Right arrow Articles by Kaplan, S. A.

Journal of Clinical Endocrinology & Metabolism, Vol 57, 356-359, Copyright © 1983 by Endocrine Society

ARTICLES

Insulin resistance in nonobese patients with polycystic ovarian disease

RJ Chang, RM Nakamura, HL Judd and SA Kaplan

To determine whether insulin resistance occurs in polycystic ovarian disease (PCO) in the absence of obesity and acanthosis nigricans, circulating levels of insulin in response to oral glucose administration were measured in 10 nonobese PCO patients without acanthosis nigricans and in 10 normal women matched for weight and height. Mean serum testosterone (T), androstenedione (A), dehydroepiandrosterone (D), D sulfate, and LH levels were significantly elevated in the PCO patients compared to those in control subjects. In PCO patients, the mean +/- SE basal insulin level (18.7 +/- 2.9 microU/ml) and the sum of the insulin levels in response to glucose (674 +/- 119 microU/ml) were significantly greater than those in the control group (11.0 +/- 0.8 microU/ml and 248 +/- 29 microU/ml, respectively). In all subjects, serum levels of T and A, but not D and D sulfate, were significantly correlated to basal insulin levels and insulin sums. Serum cortisol, GH, and PRL levels were similar in both groups. These results indicate that in PCO, a significant degree of insulin resistance exists, which clearly is not related to obesity. The positive correlation of serum T and A levels to circulating insulin levels in this study suggests that the insulin resistance in PCO may be, in part, a consequence of hyperandrogenism.


This article has been cited by other articles:


Home page
 Ann. N. Y. Acad. Sci.Home page
S. K. BLANK, K. D. HELM, C. R. MCCARTNEY, and J. C. MARSHALL
Polycystic Ovary Syndrome in Adolescence
Ann. N.Y. Acad. Sci., June 1, 2008; 1135(1): 76 - 84.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. E. Nestler
Metformin for the Treatment of the Polycystic Ovary Syndrome
N. Engl. J. Med., January 3, 2008; 358(1): 47 - 54.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
P. Vigil, P. Contreras, J. L. Alvarado, A. Godoy, A. M. Salgado, and M. E. Cortes
Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome
Hum. Reprod., November 1, 2007; 22(11): 2974 - 2980.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
C. Gagnon and J.-P. Baillargeon
Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome
Can. Med. Assoc. J., March 27, 2007; 176(7): 933 - 938.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
E. DIAMANTI-KANDARAKIS and F. ECONOMOU
Stress in Women: Metabolic Syndrome and Polycystic Ovary Syndrome
Ann. N.Y. Acad. Sci., November 1, 2006; 1083(1): 54 - 62.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
V. De Leo, M.C. Musacchio, G. Morgante, P. Piomboni, and F. Petraglia
Metformin treatment is effective in obese teenage girls with PCOS
Hum. Reprod., September 1, 2006; 21(9): 2252 - 2256.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
X. Chen, D. Yang, L. Li, S. Feng, and L. Wang
Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome
Hum. Reprod., August 1, 2006; 21(8): 2027 - 2032.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
J. Kwintkiewicz, R. Z. Spaczynski, N. Foyouzi, T. Pehlivan, and A. J. Duleba
Insulin and Oxidative Stress Modulate Proliferation of Rat Ovarian Theca-Interstitial Cells Through Diverse Signal Transduction Pathways
Biol Reprod, June 1, 2006; 74(6): 1034 - 1040.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
S. Chakrabarty, B. T. Miller, T. J. Collins, and M. Nagamani
Ovarian Dysfunction in Peripubertal Hyperinsulinemia
Reproductive Sciences, February 1, 2006; 13(2): 122 - 129.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Sam, R. S. Legro, R. Bentley-Lewis, and A. Dunaif
Dyslipidemia and Metabolic Syndrome in the Sisters of Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4797 - 4802.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Z. T. Bloomgarden
Second World Congress on the Insulin Resistance Syndrome: Mediators, pediatric insulin resistance, the polycystic ovary syndrome, and malignancy
Diabetes Care, July 1, 2005; 28(7): 1821 - 1830.
[Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
M.A. Checa, A. Requena, C. Salvador, R. Tur, J. Callejo, J.J. Espinos, F. Fabregues, J. Herrero, and (Reproductive Endocrinology Interest Group of the
Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome
Hum. Reprod. Update, July 1, 2005; 11(4): 375 - 390.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. S. Legro, P. Chiu, A. R. Kunselman, C. M. Bentley, W. C. Dodson, and A. Dunaif
Polycystic Ovaries Are Common in Women with Hyperandrogenic Chronic Anovulation but Do Not Predict Metabolic or Reproductive Phenotype
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2571 - 2579.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
J. Vrbikova and D. Cibula
Combined oral contraceptives in the treatment of polycystic ovary syndrome
Hum. Reprod. Update, May 1, 2005; 11(3): 277 - 291.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Apridonidze, P. A. Essah, M. J. Iuorno, and J. E. Nestler
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 1929 - 1935.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. O. Goodarzi, S. Erickson, S. C. Port, R. I. Jennrich, and S. G. Korenman
{beta}-Cell Function: A Key Pathological Determinant in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 310 - 315.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
K.-M. Seow, C.-C. Juan, Y.-P. Hsu, L.-T. Ho, Y.-Y. Wang, and J.-L. Hwang
Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles
Hum. Reprod., January 1, 2005; 20(1): 117 - 121.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. O. Talbott, J. V. Zborowski, J. R. Rager, M. Y. Boudreaux, D. A. Edmundowicz, and D. S. Guzick
Evidence for an Association between Metabolic Cardiovascular Syndrome and Coronary and Aortic Calcification among Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5454 - 5461.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Orio Jr., S. Palomba, L. Spinelli, T. Cascella, L. Tauchmanova, F. Zullo, G. Lombardi, and A. Colao
The Cardiovascular Risk of Young Women with Polycystic Ovary Syndrome: An Observational, Analytical, Prospective Case-Control Study
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3696 - 3701.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. A. Ganie, M. L. Khurana, M. Eunice, M. Gulati, S. N. Dwivedi, and A. C. Ammini
Comparison of Efficacy of Spironolactone with Metformin in the Management of Polycystic Ovary Syndrome: An Open-Labeled Study
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2756 - 2762.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
R. J. Norman, M. Noakes, R. Wu, M. J. Davies, L. Moran, and J. X. Wang
Improving reproductive performance in overweight/obese women with effective weight management
Hum. Reprod. Update, May 1, 2004; 10(3): 267 - 280.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
D. Cibula
Is insulin resistance an essential component of PCOS?: The influence of confounding factors
Hum. Reprod., April 1, 2004; 19(4): 757 - 759.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. A.M. de Boer, C. B. Lambalk, H. H. Hendriks, C. van Aken, E. A. van der Veen, and J. Schoemaker
Growth hormone secretion is impaired but not related to insulin sensitivity in non-obese patients with polycystic ovary syndrome
Hum. Reprod., March 1, 2004; 19(3): 504 - 509.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. J. Jakubowicz, P. A. Essah, M. Seppala, S. Jakubowicz, J.-P. Baillargeon, R. Koistinen, and J. E. Nestler
Reduced Serum Glycodelin and Insulin-Like Growth Factor-Binding Protein-1 in Women with Polycystic Ovary Syndrome during First Trimester of Pregnancy
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 833 - 839.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
K.-M. Seow, C.-C. Juan, L.-Y. Wu, Y.-P. Hsu, W.-M. Yang, Y.-L. Tsai, J.-L. Hwang, and L.-T. Ho
Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance
Hum. Reprod., January 1, 2004; 19(1): 48 - 53.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Tsilchorozidou, J. W. Honour, and G. S. Conway
Altered Cortisol Metabolism in Polycystic Ovary Syndrome: Insulin Enhances 5{alpha}-Reduction But Not the Elevated Adrenal Steroid Production Rates
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5907 - 5913.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
V. De Leo, A. la Marca, and F. Petraglia
Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome
Endocr. Rev., October 1, 2003; 24(5): 633 - 667.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P.-H. Ducluzeau, P. Cousin, E. Malvoisin, H. Bornet, H. Vidal, M. Laville, and M. Pugeat
Glucose-to-Insulin Ratio Rather than Sex Hormone-Binding Globulin and Adiponectin Levels Is the Best Predictor of Insulin Resistance in Nonobese Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3626 - 3631.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. Haakova, D. Cibula, K. Rezabek, M. Hill, M. Fanta, and J. Zivny
Pregnancy outcome in women with PCOS and in controls matched by age and weight
Hum. Reprod., July 1, 2003; 18(7): 1438 - 1441.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Diamanti-Kandarakis, J.-P. Baillargeon, M. J. Iuorno, D. J. Jakubowicz, and J. E. Nestler
A Modern Medical Quandary: Polycystic Ovary Syndrome, Insulin Resistance, and Oral Contraceptive Pills
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 1927 - 1932.
[Full Text] [PDF]

Home page
 Endocr. Rev.Home page
F. C. W. Wu and A. von Eckardstein
Androgens and Coronary Artery Disease
Endocr. Rev., April 1, 2003; 24(2): 183 - 217.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. S. George, K. George, C. Irwin, V. Job, R. Selvakumar, V. Jeyaseelan, and M.S. Seshadri
Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomized, controlled trial
Hum. Reprod., February 1, 2003; 18(2): 299 - 304.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Morin-Papunen, I. Vauhkonen, R. Koivunen, A. Ruokonen, H. Martikainen, and J. S. Tapanainen
Metformin Versus Ethinyl Estradiol-Cyproterone Acetate in the Treatment of Nonobese Women with Polycystic Ovary Syndrome: A Randomized Study
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 148 - 156.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. Kaaks, A. Lukanova, and M. S. Kurzer
Obesity, Endogenous Hormones, and Endometrial Cancer Risk: A Synthetic Review
Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1531 - 1543.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
K. Elter, G. Imir, and F. Durmusoglu
Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study
Hum. Reprod., July 1, 2002; 17(7): 1729 - 1737.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
D. Cibula, M. Fanta, M. Hill, G. Sindelka, J. Skrha, and J. Zivny
Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin
Hum. Reprod., January 1, 2002; 17(1): 76 - 82.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. M. Koivunen, L. C. Morin-Papunen, A. Ruokonen, J. S. Tapanainen, and H. K. Martikainen
Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin
Hum. Reprod., December 1, 2001; 16(12): 2546 - 2551.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
C. G. Solomon, F. B. Hu, A. Dunaif, J. Rich-Edwards, W. C. Willett, D. J. Hunter, G. A. Colditz, F. E. Speizer, and J. E. Manson
Long or Highly Irregular Menstrual Cycles as a Marker for Risk of Type 2 Diabetes Mellitus
JAMA, November 21, 2001; 286(19): 2421 - 2426.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. Ciotta, A. E. Calogero, M. Farina, V. De Leo, A. La Marca, and A. Cianci
Clinical, endocrine and metabolic effects of acarbose, an {alpha}-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance
Hum. Reprod., October 1, 2001; 16(10): 2066 - 2072.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Azziz, D. Ehrmann, R. S. Legro, R. W. Whitcomb, R. Hanley, A. G. Fereshetian, M. O’Keefe, and M. N. Ghazzi
Troglitazone Improves Ovulation and Hirsutism in the Polycystic Ovary Syndrome: A Multicenter, Double Blind, Placebo-Controlled Trial
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1626 - 1632.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
S. Morimoto, C. Fernandez-Mejia, G. Romero-Navarro, N. Morales-Peza, and V. DÍaz-Sánchez
Testosterone Effect on Insulin Content, Messenger Ribonucleic Acid Levels, Promoter Activity, and Secretion in the Rat
Endocrinology, April 1, 2001; 142(4): 1442 - 1447.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. J. Jakubowicz, M. Seppälä, S. Jakubowicz, O. Rodriguez-Armas, A. Rivas-Santiago, H. Koistinen, R. Koistinen, and J. E. Nestler
Insulin Reduction with Metformin Increases Luteal Phase Serum Glycodelin and Insulin-Like Growth Factor-Binding Protein 1 Concentrations and Enhances Uterine Vascularity and Blood Flow in the Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1126 - 1133.
[Abstract] [Full Text]

Home page
 Hum ReprodHome page
M.W. Elting, T.J.M. Korsen, P.D. Bezemer, and J. Schoemaker
Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population
Hum. Reprod., March 1, 2001; 16(3): 556 - 560.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
L. Ibáñez, J. DiMartino-Nardi, N. Potau, and P. Saenger
Premature Adrenarche--Normal Variant or Forerunner of Adult Disease?
Endocr. Rev., December 1, 2000; 21(6): 671 - 696.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. C. Morin-Papunen, I. Vauhkonen, R. M. Koivunen, A. Ruokonen, H. K. Martikainen, and J. S. Tapanainen
Endocrine and Metabolic Effects of Metformin Versus Ethinyl Estradiol-Cyproterone Acetate in Obese Women with Polycystic Ovary Syndrome: A Randomized Study
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3161 - 3168.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
D. Deplewski and R. L. Rosenfield
Role of Hormones in Pilosebaceous Unit Development
Endocr. Rev., August 1, 2000; 21(4): 363 - 392.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
P. J. Marsden, A. P. Murdoch, and R. Taylor
Adipocyte insulin action in hypogonadotrophic hypogonadism
Hum. Reprod., August 1, 2000; 15(8): 1672 - 1678.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
R. A. Lobo and E. Carmina
The Importance of Diagnosing the Polycystic Ovary Syndrome
Ann Intern Med, June 20, 2000; 132(12): 989 - 993.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. C. Morin-Papunen, I. Vauhkonen, R. M. Koivunen, A. Ruokonen, and J. S. Tapanainen
Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome
Hum. Reprod., June 1, 2000; 15(6): 1266 - 1274.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. Ciotta, V. De Leo, F. Galvani, A. La Marca, and A. Cianci
Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia
Hum. Reprod., December 1, 1999; 14(12): 2951 - 2958.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
I.R. Pirwany, R.W.S. Yates, I.T. Cameron, and R. Fleming
Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea
Hum. Reprod., December 1, 1999; 14(12): 2963 - 2968.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Lemieux, G. F. Lewis, A. Ben-Chetrit, G. Steiner, and E. M. Greenblatt
Correction of Hyperandrogenemia by Laparoscopic Ovarian Cautery in Women with Polycystic Ovarian Syndrome Is Not Accompanied by Improved Insulin Sensitivity or Lipid-Lipoprotein Levels
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4278 - 4282.
[Abstract] [Full Text]

Home page
 Hum ReprodHome page
M.F.M. Mitwally, N.K. Kuscu, and T.M. Yalcinkaya
High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome
Hum. Reprod., November 1, 1999; 14(11): 2700 - 2703.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
P. J.Marsden, A. P. Murdoch, and R. Taylor
Adipocyte insulin action following ovulation in polycystic ovarian syndrome
Hum. Reprod., September 1, 1999; 14(9): 2216 - 2222.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice
The Insulin-Related Ovarian Regulatory System in Health and Disease
Endocr. Rev., August 1, 1999; 20(4): 535 - 582.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
P. A. RADON, M. J. MCMAHON, and W. R. MEYER
Impaired Glucose Tolerance in Pregnant Women With Polycystic Ovary Syndrome
Obstet. Gynecol., August 1, 1999; 94(2): 194 - 197.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M.B. Tiras, R. Yalcin, V. Noyan, I. Maral, M. Yildirim, O. Dortlemez, and S. Daya
Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome
Hum. Reprod., August 1, 1999; 14(8): 1949 - 1952.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Wahrenberg, I. Ek, S. Reynisdottir, K. Carlström, A. Bergqvist, and P. Arner
Divergent Effects of Weight Reduction and Oral Anticonception Treatment on Adrenergic Lipolysis Regulation in Obese Women with the Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2182 - 2187.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. S. Legro, A. R. Kunselman, W. C. Dodson, and A. Dunaif
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women
J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 165 - 169.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. P. Diamond, D. Grainger, M. C. Diamond, R. S. Sherwin, and R. A. DeFronzo
Effects of Methyltestosterone on Insulin Secretion and Sensitivity In Women
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4420 - 4425.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. S. Legro, D. Finegood, and A. Dunaif
A Fasting Glucose to Insulin Ratio Is a Useful Measure of Insulin Sensitivity in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2694 - 2698.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Diamanti-Kandarakis, A. Mitrakou, S. Raptis, G. Tolis, and A. J. Duleba
The Effect of a Pure Antiandrogen Receptor Blocker, Flutamide, on the Lipid Profile in the Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2699 - 2705.
[Abstract] [Full Text]